Table 3. Detection of LHX2 in serum of patients with cervical cancer by ELISA.
| Number | Before treatment | Being treatment | After treatment |
|---|---|---|---|
| 800***286 | 0.516 | 0.443 | – |
| 800***672 | 0.5 | 0.543 | 0.469 |
| 800***441 | 0.505 | 0.544 | 0.538 |
| 800***734 | 0.526 | – | 0.524 |
| 800***502 | 0.536 | 0.611 | 0.571 |
| 800***752 | 0.493 | 0.524 | – |
| 800***001 | 0.541 | 0.539 | 0.443 |
| 800***006 | 0.497 | 0.561 | 0.602 |
| 800***978 | 0.499 | 0.567 | 0.556 |
| 800***084 | – | 0.464 | 0.463 |
| 800***657 | 0.445 | 0.521 | – |
| 800***531 | 0.533 | 0.52 | 0.513 |
| 800***869 | 0.522 | 0.495 | 0.557 |
| 800***300 | 0.533 | 0.532 | 0.537 |
| 800***588 | 0.632 | 0.604 | 0.618 |
| 800***518 | 0.603 | – | 0.584 |
| 800***921 | 0.497 | 0.548 | – |
| 800***347 | 0.482 | – | – |
| 800***647 | 0.519 | 0.611 | 0.627 |
| 800***814 | 0.628 | 0.589 | 0.526 |
| 800***418 | 0.589 | – | 0.504 |
| 800***161 | 0.415 | 0.426 | 0.432 |
ELISA, enzyme-linked immunosorbent assay.